Literature DB >> 8065404

The impact of HLA mismatches on the survival of first cadaveric kidney transplants.

P J Held1, B D Kahan, L G Hunsicker, D Liska, R A Wolfe, F K Port, D S Gaylin, J R Garcia, L Y Agodoa, H Krakauer.   

Abstract

BACKGROUND: The benefits of HLA-A, B, and DR matching of cadaveric kidney grafts and recipients remain controversial when viewed from the perspective of social equity and graft survival.
METHODS: We estimated graft survival using proportional-hazards techniques, adjusting for patient and donor characteristics, for a series of 30,564 Medicare patients receiving a first cadaveric kidney transplant between 1984 and 1990. The effects of minimal achievable HLA mismatches and maximal matching on graft survival were estimated by simulated allocation of a sample of organs to a sample of 20,000 candidates for transplantation.
RESULTS: The adjusted one-year graft survival was 84.3 percent for grafts with no mismatches and 77.0 percent for grafts with four mismatches. National rationing of donor organs to achieve minimal mismatching and maximal matching could potentially decrease the average number of HLA mismatches from 3.6 to 1.2, with a corresponding increase in the number of matches. As a consequence, projected five-year graft survival could potentially increase from 58.5 percent to 62.9 percent. This would be associated with a decrease in the proportion of kidneys allocated to black recipients from 22.2 to 15.0 percent.
CONCLUSIONS: Under ideal circumstances, a policy of maximal matching of cadaveric renal transplants would increase five-year graft survival by a comparatively small 4.4 percentage points, but the actual benefit is likely to be smaller.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8065404     DOI: 10.1056/NEJM199409223311203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  21 in total

1.  Kidney transplant candidates' views of the transplant allocation system.

Authors:  O N Louis; P Sankar; P A Ubel
Journal:  J Gen Intern Med       Date:  1997-08       Impact factor: 5.128

Review 2.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

3.  Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention.

Authors:  A J Demetris; N Murase; T E Starzl; J J Fung
Journal:  Graft (Georget Tex)       Date:  1998-05

Review 4.  Transplant genetics and genomics.

Authors:  Joshua Y C Yang; Minnie M Sarwal
Journal:  Nat Rev Genet       Date:  2017-03-13       Impact factor: 53.242

5.  A Risk Index for Living Donor Kidney Transplantation.

Authors:  A B Massie; J Leanza; L M Fahmy; E K H Chow; N M Desai; X Luo; E A King; M G Bowring; D L Segev
Journal:  Am J Transplant       Date:  2016-02-26       Impact factor: 8.086

6.  Using a standardized donor ratio to assess the performance of organ procurement organizations.

Authors:  Sheryl Stogis; Richard A Hirth; Robert L Strawderman; Jane Banaszak-Holl; Dean G Smith
Journal:  Health Serv Res       Date:  2002-10       Impact factor: 3.402

7.  Consideration of donor age and human leukocyte antigen matching in the setting of multiple potential living kidney donors.

Authors:  Michael D Rizzari; Thomas M Suszynski; Kristen J Gillingham; Arthur J Matas
Journal:  Transplantation       Date:  2011-07-15       Impact factor: 4.939

8.  Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.

Authors:  Stefan O Ciurea; Peter F Thall; Xuemei Wang; Sa A Wang; Ying Hu; Pedro Cano; Fleur Aung; Gabriela Rondon; Jeffrey J Molldrem; Martin Korbling; Elizabeth J Shpall; Marcos de Lima; Richard E Champlin; Marcelo Fernandez-Vina
Journal:  Blood       Date:  2011-10-03       Impact factor: 22.113

Review 9.  Renal transplantation in high-risk patients.

Authors:  Nicole A Weimert; Rita R Alloway
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.

Authors:  Stefan O Ciurea; Marcos de Lima; Pedro Cano; Martin Korbling; Sergio Giralt; Elizabeth J Shpall; Xuemei Wang; Peter F Thall; Richard E Champlin; Marcelo Fernandez-Vina
Journal:  Transplantation       Date:  2009-10-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.